A new kind of flu vaccine made with mRNA technology will soon be available. Marco Bello/Bloomberg/Getty Images hide caption toggle caption Marco Bello/Bloomberg/Getty Images For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter. The Food and Drug Administration approved Moderna’s mRNA-based vaccine against seasonal influenza for people 50 and older,